Background: Studies related to blood type in cancer patients have been conducted
extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is …

Objective: This study aimed to assess the occurrence of chemotherapy-induced nausea and
vomiting (CINV) in acute phase (24 h after chemotherapy) and delayed phase (2–5 days …

Cancer patients experience a considerable number of symptoms during the course of their
disease. Of these symptoms, chemotherapy-induced nausea and vomiting (CINV) is one of …

Background The major objective of the study was to determine the incidence and
prevalence of acute and delayed chemotherapy-induced nausea and vomiting (CINV) …

Goals of work The present study sought to determine the prevalence of acute and delayed
chemotherapy-induced nausea and vomiting (CINV) across ten community oncology …

Background This study aimed to explore the subjective experience of nausea and vomiting
during chemotherapy treatment among breast cancer patients and the impacts on their daily …

Background: health practitioners, especially oncology nurses, play an important role in
assessing and managing chemotherapy-induced nausea and vomiting (CINV). Oncology …

PURPOSE: To examine nurses' roles in the prevention and management of chemotherapy-
induced nausea and vomiting (CINV), and to identify their related educational needs …

Background Unrelieved chemotherapy-induced nausea (CIN) occurs 48% of patients
undergoing chemotherapy and is one of the most debilitating symptoms that patients report …

Purpose To explore the actual status of chemotherapy-induced nausea and vomiting (CINV)
through a multicenter prospective cohort study. Methods Patients with breast cancer treated …